Have a personal or library account? Click to login
Breaking the pain barrier: implantable intrathecal pump therapy as a game-changer in cancer pain management Cover

Breaking the pain barrier: implantable intrathecal pump therapy as a game-changer in cancer pain management

Radiology and Oncology
Volume 59 (2025): Issue 4 (December 2025)
By: Iztok Potocnik,  Branka Strazisar,  Helena Lenasi and  Teodora Zupanc  
Open Access
|Dec 2025

References

  1. Zhang H. Cancer pain management-new therapies. Curr Oncol Rep 2022; 24: 223-6. doi: 10.1007/s11912-021-01166-z
    Open DOISearch in Google ScholarBack to article
  2. Bandara S, Bicket MC, McGinty EE. Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012-2019. PLoS ONE 2022; 17: e0272142. doi: 10.1371/journal.pone.0272142
    Open DOISearch in Google ScholarBack to article
  3. Daud ML, Simone GG. Management of pain in cancer patients - an update. Ecancermedicalscience 2024; 18: 1821. doi: 10.3332/ecancer.2024.1821
    Open DOISearch in Google ScholarBack to article
  4. Bhatia G, Lau ME, Koury KM, Gulur P. Intrathecal Drug Delivery (ITDD) systems for cancer pain. F1000Res 2013; 2: 96. doi: 10.12688/f1000research.2-96.v4
    Open DOISearch in Google ScholarBack to article
  5. Gilmer-Hill HS, Boggan JE, Smith KA, Wagner FC Jr. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. Surg Neurol 1999; 51: 12-5. doi: 10.1016/s0090-3019(98)00080-9
    Open DOISearch in Google ScholarBack to article
  6. Dupoiron D, Duarte R, Carvajal G, Aubrun F, Eldabe S. Rationale and recent advances in targeted drug delivery for cancer pain: Is it time to change the paradigm? Pain Physician 2022; 25: E414-E425
    Search in Google ScholarBack to article
  7. Goel V, Kaizer A, Darrow D, Rosielle D, Owens B, Blaes A. Cancer patients quality of life after intrathecal drug delivery for advanced pain management: a patient-reported outcome analysis. Pain Med 2025; 26: 261-8. doi: 10.1093/pm/pnaf012
    Open DOISearch in Google ScholarBack to article
  8. Green P, Schneider A, Lange J. Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products. MAbs 2024; 16: 2402713. doi: 10.1080/19420862.2024.2402713
    Open DOISearch in Google ScholarBack to article
  9. Abd-Sayed A, Fiala K, Weisbein J, Chopra P, Lam C, Kalia H, et al. Intrathecal drug delivery systems survey: Trends in utilization in pain practice. J Pain Res 2022; 15: 1305-14. doi: 10.2147/JPR.S344409
    Open DOISearch in Google ScholarBack to article
  10. Wilkes D. Programmable intrathecal pumps for the management of chronic pain: recommendations for improved efficiency. J Pain Res 2014; 7: 571-7. doi: 10.2147/JPR.S46929
    Open DOISearch in Google ScholarBack to article
  11. Chalil A, Staudt MD, Harland TA, Leimer EM, Bhullar R, Argoff CE. A safety review of approved intrathecal analgesics for chronic pain management. Expert Opin Drug Saf 2021; 20: 439-51. doi: 10.1080/14740338.2021.1889513
    Open DOISearch in Google ScholarBack to article
  12. Perruchoud C, Dupoiron D, Papi B, Calabrese A, Brogan SE. Management of cancer-related pain with intrathecal drug delivery: A systematic review and meta-analysis of clinical studies. Neuromodulation 2023; 26: 1142-52. doi: 10.1016/j.neurom.2021.12.004
    Open DOISearch in Google ScholarBack to article
  13. Grandhi RK, White RS, Chen KY, Nair S, Hall C, Shaparin N. Does opioid use cause angiogenesis and metastasis? Pain Med 2017; 18: 140-6. doi: 10.1093/pm/pnw161
    Open DOISearch in Google ScholarBack to article
  14. Wang R, Li S, Wang B, Zheng H, Wang G. Impact of opioids and mu-opioid receptors on oncologic metastasis. Am J Cancer Res 2024; 14: 4236-47. doi: 10.62347/SCLS3277
    Open DOISearch in Google ScholarBack to article
  15. World Health Organization. Cancer pain relief: With a guide to opioid availability. 2nd ed. Geneva: WHO; 1996. Available from: https://apps.who.int/iris/handle/10665/37896
    Search in Google ScholarBack to article
  16. Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol2012; 23: 139-54. doi: 10.1093/annonc/mds233
    Open DOISearch in Google ScholarBack to article
  17. Sessler DI, Riedel B. Anesthesia and cancer recurrence: Context and perspective. Anesthesiology 2019; 130: 3-5. doi: 10.1097/ALN.0000000000002506
    Open DOISearch in Google ScholarBack to article
  18. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002; 20: 4040-9. doi: 10.1200/JCO.2002.02.118
    Open DOISearch in Google ScholarBack to article
  19. Novy DM, Aigner CJ. The biopsychosocial model in cancer pain. Curr Opin Support Palliat Care 2014; 8: 117-23. doi: 10.1097/SPC.0000000000000046
    Open DOISearch in Google ScholarBack to article
  20. Benrath J, Hatzenbühler M, Fresenius M, Heck M. Repetitorium Schmerztherapie: Zur Vorbereitung auf die Prüfung “Spezielle Schmerztherapie”. 4. Aufl. Heidelberg: Springer; 2015. doi: 10.1007/978-3-662-47865-3
    Open DOISearch in Google ScholarBack to article
  21. Dupoiron D. Cancer pain management: A European perspective. Cancer Treat Res 2021; 182: 39-55. doi: 10.1007/978-3-030-81526-4_4
    Open DOISearch in Google ScholarBack to article
  22. Dupoiron D. Intrathecal therapy for pain in cancer patients. Curr Opin Support Palliat Care. 2019; 13: 75-80. doi: 10.1097/SPC.0000000000000427
    Open DOISearch in Google ScholarBack to article
  23. Warner LL, Moeschler SS, Pittelkow TP, Strand JJ. Attitudes of hospice providers regarding intrathecal targeted drug delivery for patients with cancer. Am J Hosp Palliat Care 2019; 36: 955-8. doi: 10.1177/1049909119852928
    Open DOISearch in Google ScholarBack to article
  24. Wang W, Shi Q, Cao Y, Fan B, Yang Y. Intrathecal drug delivery systems for cancer pain: A retrospective analysis at a single tertiary medical center in China. Heliyon 2024; 10: e34522. doi: 10.1016/j.heliyon.2024.e34522. PMID: 39114043; PMCID: PMC11305181.
    Open DOISearch in Google ScholarBack to article
  25. Hamza M, Doleys DM, Wells M, Weisbein J, Hoff J, Martin M, et al. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med 2012; 13: 1304-13. doi: 10.1111/j.1526-4637.2012.01451.x
    Open DOISearch in Google ScholarBack to article
  26. Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain. 2003; 4: 441-7. doi: 10.1067/s1526-5900(03)00730-2
    Open DOISearch in Google ScholarBack to article
  27. Bolash R, Udeh B, Saweris Y, Guirguis M, Dalton JE, Makarova N, et al. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients. Neuromodulation 2015; 18: 150-5; discussion 155-6. doi: 10.1111/ner.12235
    Open DOISearch in Google ScholarBack to article
  28. De Andrés J, Rubio-Haro R, De Andres-Serrano C, Asensio-Samper JM, Fabregat-Cid G. Intrathecal drug delivery. Methods Mol Biol 2020; 2059: 75-108. doi: 10.1007/978-1-4939-9798-5_3
    Open DOISearch in Google ScholarBack to article
  29. De Andres J, Hayek S, Perruchoud C, Lawrence MM, Reina MA, De Andres-Serrano C, et al. Intrathecal drug delivery: Advances and applications in the management of chronic pain patient. Front Pain Res (Lausanne) 2022; 3: 900566. doi: 10.3389/fpain.2022.900566
    Open DOISearch in Google ScholarBack to article
  30. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17: 45-56. doi: 10.1016/0304-3959(83)90126-4
    Open DOISearch in Google ScholarBack to article
  31. European Organisation for Research and Treatment of Cancer (EORTC). EORTC QLQ-C30: Quality of Life Questionnaire - Core 30, English Version. Brussels: EORTC; 2018 [cited 2024 June 17]. Available from: https://www. eortc.org/app/uploads/sites/2/2018/08/Specimen-QLQ-C30-English.pdf.
    Search in Google ScholarBack to article
  32. Alberta Health Services. Edmonton Symptom Assessment System Revised (ESAS-r) Form [Internet]. Alberta Health Services; 2015 [cited 2024 Dec 17]. Available from: https://www.albertahealthservices.ca/frm-07903.pdf
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/raon-2025-0060 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 477 - 487
Submitted on: May 9, 2025
|
Accepted on: Sep 6, 2025
|
Published on: Dec 16, 2025
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
cancer pain,
intrathecal drug delivery,
implantable pumps,
palliative care,
opioid-sparing therapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2025 Iztok Potocnik, Branka Strazisar, Helena Lenasi, Teodora Zupanc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 59 (2025): Issue 4 (December 2025)Next article